These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6154996)

  • 1. [Foot-and-mouth disease viral strain study].
    Karpovich MB; Kruglikov BA; Salazhov EL
    Veterinariia; 1980 Jan; (1):22-3. PubMed ID: 6154996
    [No Abstract]   [Full Text] [Related]  

  • 2. Mimicking foot-and-mouth disease virus antigens with synthetic peptides.
    Rowlands DJ
    Ann Sclavo Collana Monogr; 1984; 1(2):147-61. PubMed ID: 6100728
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differences in the antigenic structure of strains of the foot-and-mouth disease virus].
    Sobko AI; Koshetsian EG; Kochergina MF; Shevardin AN; Perevozchikov VA
    Veterinariia; 1974 Sep; (9):36-8. PubMed ID: 4143073
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative single radial immunodiffusion of foot-and-mouth disease viral antigens using convalescent cattle sera.
    Tsuda T; Namba K; Yamasaki Y; Nilchavee S; Pattanaprasit N; Sinchongsubongkoie W; Onodera T
    Nihon Juigaku Zasshi; 1987 Jun; 49(3):461-8. PubMed ID: 3039224
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative trial of the immunogenic properties of commercial foot-and-mouth virus strains].
    Tekerlekov P; Nikolova E
    Vet Med Nauki; 1981; 18(1):19-26. PubMed ID: 6272473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of antigen content and effectiveness of foor-and-mouth disease vaccines.
    Czelleng F; Sólyom F
    Dev Biol Stand; 1976; 35():295-6. PubMed ID: 198298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possibilities of biophysicochemical antigen control in vaccine production using foot-and-mouth disease virus as an example (review)].
    Liebermann H; Kwasniowski W; Strebelow G
    Arch Exp Veterinarmed; 1988 Mar; 42(2):165-73. PubMed ID: 2840042
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenic quality of foot-and-mouth disease virus.
    Strobbe R
    Dev Biol Stand; 1976; 35():311-21. PubMed ID: 198301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Storage-related potency changes in monovalent type O1, A5 and C foot-and-mouth disease vaccine preparations.
    Sólyom F; Fazekas A; Czelleng F
    Acta Vet Acad Sci Hung; 1981; 28(3):289-95. PubMed ID: 6266237
    [No Abstract]   [Full Text] [Related]  

  • 10. [Foot and mouth disease induced by a vaccinal strain of the virus].
    Bychkovskii VN
    Vrach Delo; 1972 Aug; 8():150-1. PubMed ID: 4342149
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of virus infection-associated antigen and 3D antibodies in cattle vaccinated against foot and mouth disease.
    O'Donnell VK; Smitsaart E; Cetra B; Duffy S; Finelli J; Boyle D; Draghi G; Fondevila N; Schudel AA
    Rev Sci Tech; 1997 Dec; 16(3):833-40. PubMed ID: 9567309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of the correspondence of epizootic strains of the foot-and-mouth disease virus to the cultured ones].
    Cherniaev IuA; Sobko AI
    Veterinariia; 1973 Jan; 49(1):43-6. PubMed ID: 4356958
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of immuno-peroxidase techniques for the detection of foot-and mouth disease virus antigens.
    Sutmoller P; Cowan KM
    Proc Annu Meet U S Anim Health Assoc; 1974; (78):181-7. PubMed ID: 4377950
    [No Abstract]   [Full Text] [Related]  

  • 14. Localization of foot-and-mouth disease viral antigens in mammary gland of infected cows.
    Blackwell JH; Yilma T
    Am J Vet Res; 1981 May; 42(5):770-3. PubMed ID: 6266292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of persistent aphthovirus infection and its differentiation from vaccination response in cattle by use of enzyme-linked immunoelectrotransfer blot analysis with bioengineered nonstructural viral antigens.
    Bergmann IE; de Mello PA; Neitzert E; Beck E; Gomes I
    Am J Vet Res; 1993 Jun; 54(6):825-31. PubMed ID: 8391765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of foot-and-mouth disease virus infection-associated antigen.
    Morgan DO; Moore DM; McKercher PD
    Proc Annu Meet U S Anim Health Assoc; 1978; (82):277-83. PubMed ID: 221935
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of vaccination against foot-and-mouth disease on results of the immunodiffusion test for the demonstration of precipitating bovine leukosis virus antibodies].
    Straub OC
    Dtsch Tierarztl Wochenschr; 1983 Apr; 90(4):135-7. PubMed ID: 6305624
    [No Abstract]   [Full Text] [Related]  

  • 18. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
    Dunn CS; Samuel AR; Pullen LA; Anderson J
    Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antigenic properties of the foot-and-mouth disease virus concentrated by polyethylene glycol].
    Sobko AI; Prokhorov VN; Sokolov LN; Koshetsian EG
    Veterinariia; 1973 May; 49(5):67-8. PubMed ID: 4353691
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantification, characterisation and safety testing of foot-and-mouth disease virus antigens eluted from alhydrogel vaccines.
    Visser N; Woortmeyer R
    Dev Biol Stand; 1981; 50():277-83. PubMed ID: 6176487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.